Recent thoughts on management and prevention of recurrent early pregnancy loss

Current Opinion in Obstetrics and Gynecology

Volumn 22, Issue 6, 2010, Pages 446-451

  Tang, Ai Wei ^a   Quenby, Siobhan ^b  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

live birth rates; management; pregnancy outcome; recurrent pregnancy loss

Indexed keywords

ACETYLSALICYLIC ACID; BROMOCRIPTINE; CHORIONIC GONADOTROPIN; CLOMIFENE; HEPARIN; IMMUNOGLOBULIN; LEVOTHYROXINE; LOW MOLECULAR WEIGHT HEPARIN; METFORMIN; PLACEBO; PREDNISOLONE; PROGESTERONE; THYROID ANTIBODY;

ANATOMICAL VARIATION; ANTICOAGULANT THERAPY; ANTIPHOSPHOLIPID SYNDROME; CLINICAL TRIAL; GLUCOSE METABOLISM; HEREDITY; HUMAN; HYPERPROLACTINEMIA; IDIOPATHIC DISEASE; IMMUNOTHERAPY; KARYOTYPE; LOW DRUG DOSE; LUTEAL INSUFFICIENCY; NATURAL KILLER CELL; OBSERVATIONAL STUDY; OVARY POLYCYSTIC DISEASE; PREGNANCY DISORDER; PREGNANCY OUTCOME; PRIORITY JOURNAL; PROGNOSIS; RECURRENT DISEASE; RECURRENT PREGNANCY LOSS; REVIEW; THROMBOPHILIA; THYROID DISEASE;

ABORTION, HABITUAL; ENDOCRINE SYSTEM DISEASES; FEMALE; HUMANS; IMMUNE SYSTEM PHENOMENA; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, FIRST; UTERUS;

EID: 78449244863     PISSN: 1040872X     EISSN: None     Source Type: Journal    
DOI: 10.1097/GCO.0b013e32833e124e     Document Type: Review

References (50)

1. Stirrat GM. Recurrent miscarriage. Lancet 1990; 336:673-675.
2. Farquharson RG, Jauniaux E, Exalto N. Updated and revised nomenclature for description of early pregnancy events. Hum Reprod 2005; 20:3008-3011.
3. Habayeb OM, Konje JC. Theone-stopre currentmis carriage clinic: anevaluation of its effectiveness and outcome. Hum Reprod 2004; 19:2952-2958.
4. Quenby SM, Farquharson RG. Predicting recurring miscarriage: what is important?Obstet Gynecol 1993; 82:132-138.
5. Hogge WA, Byrnes AL, Lanasa MC, Surti U. The clinical use of karyotyping spontaneousabortions. Am J Obstet Gynecol 2003; 189:397-400;discussion 400-402.
6. Stephenson MD, Sierra S. Reproductive outcomes in recurrent pregnancy loss associated with a parental carrier of a structural chromosome rearrangement. Hum Reprod 2006; 21:1076-1082.
7. Saravelos SH, Cocksedge KA, Li TC. Prevalence and diagnosis of congenital uterineanomalies in womenwith reproductivefailure: acritical appraisal. Hum Reprod Update 2008; 14:415-429.
8. Greaves M, Cohen H, Machin SJ, Mackie I. Guidelines on the investigation and management of the antiphospholipid syndrome. Br J Haematol 2000; 109:704-715.
9. Rey E, Kahn SR, David M, Shrier I. Thrombophilic disorders and fet al loss: a meta-analysis. Lancet 2003; 361:901-908.
10. Arredondo F, Noble LS. Endocrinology of recurrent pregnancy loss. Semin Reprod Med 2006; 24:33-39.
11. Barber JC, Cockwell AE, Grant E, et al. Is karyotyping couples experiencing recurrent miscarriage worth the cost? BJOG 2010; 117:885-888.
12. Franssen MT, Korevaar JC, van der Veen F, et al. Reproductive outcome after chromosome analysis in couples with two or more miscarriages: index [corrected]-control study. BMJ 2006; 332:759-763.
13. Fischer J, Colls P, Escudero T, Munné S. Preimplantation genetic diagnosis (PGD) improves pregnancyoutcomefortranslocation carrierswith ahistoryof recurrent losses. Fertil Steril 2010; 94:283-289.
14. Valli E, Vaquero E, Lazzarin N, et al. Hysteroscopic metroplasty improves gestational outcome in women with recurrent spontaneous abortion. J Am Assoc Gynecol Laparosc 2004; 11:240-244.
15. Roy KK, Singla S, Baruah J, et al. Reproductive outcome following hystero-scopic septal resection in patients with infertility and recurrent abortions. Arch Gynecol Obstet 2009. [Epub ahead of print]
16. Kowalik CR, Mol BW, Veersema S, Goddijn M. Criticalappraisal regardingthe effect on reproductive outcome of hysteroscopic metroplasty in patients with recurrent miscarriage. Arch Gynecol Obstet 2010. [Epub ahead of print]
17. Gavai M, Berkes E, Lazar L, et al. Factors affecting reproductive outcome following abdominal myomectomy. J Assist Reprod Genet 2007; 24:525-531.
18. Yu D, Wong YM, Cheong Y, et al. Asherman syndrome: one century later. Fertil Steril 2008; 89:759-779.
19. ACOG practice bulletin. Management of recurrent pregnancy loss. Number 24, February 2001. (Replaces Technical Bulletin Number 212 September 1995). American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet 2002;78: 179-190.
20. Brenner B, Bar J, Ellis M, et al. Effects of enoxaparin on late pregnancy complications and neonatal outcome in women with recurrent pregnancy loss and thrombophilia: results from the Live-Enox study. Fertil Steril 2005; 84:770-773.
21. Deligiannidis A, Parapanissiou E, Mavridis P, et al. Thrombophilia and anti-thrombotic therapy in women with recurrent spontaneous abortions. J Reprod Med 2007; 52:499-502.
22. Laskin CA, Spitzer KA, Clark CA, et al. Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA Trial. J Rheumatol 2009; 36:279-287.
23. Kaandorp SP,Goddijn M,van derPost JA, et al.Aspirin plus heparin or aspirin alone in women with recurrent miscarriage. N Engl J Med 2010; 362: 1586-1596.
24. Cocksedge KA, Li TC, Saravelos SH, Metwally M. A reappraisal of the role of polycystic ovary syndrome in recurrent miscarriage. Reprod Biomed Online 2008; 17:151-160.
25. Clark AM, Ledger W, Galletly C, et al. Weight loss results in significant improvement in pregnancy and ovulation rates in anovulatory obese women. Hum Reprod 1995; 10:2705-2712.
26. Zolghadri J, Tavana Z, Kazerooni T, et al. Relationship between abnormal glucose tolerance test and history of previous recurrent miscarriages, and beneficial effect of metformin in these patients: a prospective clinical study. Fertil Steril 2008; 90:727-730.
27. Legro RS, Barnhart HX, Schlaff WD, et al. Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome. N Engl J Med 2007; 356:551-566.
28. Li TC, Spuijbroek MD, Tuckerman E, et al. Endocrinological and endometrial factors in recurrent miscarriage. BJOG 2000; 107:1471-1479.
29. Hirahara F,Andoh N, Sawai K, et al. Hyperprolactinemic recurrentmiscarriage and results of randomized bromocriptine treatment trials. Fertil Steril 1998; 70:246-252.
30. Royal College of Obstetricians and Gynaecologists. The investigation and treatment for couples with recurrent miscarriage. 2003. http://www.rcog.org.uk/ womens-health/clinical-guidance/investigation-and-treatment-couples-recurrent- miscarriage-green-top-.
31. Quenby S, Farquharson RG. Human chorionicgonadotropinsupplementation in recurring pregnancy loss:acontrolled trial. Fertil Steril1994; 62:708-710.
32. Bansal AS. Joining the immunological dots in recurrent miscarriage. Am J Reprod Immunol 2010. [Epub ahead of print]
33. Rai RS, Regan L, Clifford K, et al. Antiphospholipid antibodies and beta 2-glycoprotein-I in 500 women with recurrent miscarriage: results of a comprehensive screening approach. Hum Reprod 1995; 10:2001-2005.
34. Empson MB, Lassere M, Craig JC, Scott JR. Prevention of recurrent mis-carriage for women with antiphospholipid antibody or lupus anticoagulant. Cochrane Database Syst Rev 2005:CD002859.
35. Farquharson RG, Quenby S, Greaves M. Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment. Obstet Gynecol 2002; 100:408-413.
36. Stagnaro-Green A, Glinoer D. Thyroid autoimmunity and the risk of miscar-riage. Best Pract Res Clin Endocrinol Metab 2004; 18:167-181.
37. Vaquero E, Lazzarin N, De Carolis C, et al. Mild thyroid abnormalities and recurrent spontaneous abortion: diagnostic and therapeutical approach. Am J Reprod Immunol 2000; 43:204-208.
38. Dosiou C,Giudice LC. Naturalkillercells in pregnancyand recurrentpregnancy loss: endocrine and immunologic perspectives. Endocr Rev 2005; 26:44-62.
39. Quenby S, Nik H, Innes B, et al. Uterine natural killercellsand angiogenesis in recurrent reproductive failure. Hum Reprod 2009; 24:45-54.
40. Tuckerman E, Laird SM, Prakash A, Li TC. Prognostic value of the measure-mentofuterine natural killercells in the endometrium of women with recurrent miscarriage. Hum Reprod 2007; 22:2208-2213.
41. Tang AW, Alfirevic Z, Turner MA, et al. Prednisolone trial: study protocol for a randomised controlled trial of prednisolone for women with idiopathic recurrent miscarriage and raised levels of uterine natural killer (uNK) cells in the endometrium. Trials 2009; 10:102.
42. Laird SM, Tuckerman EM, Cork BA, et al. A review of immune cells and molecules in women with recurrent miscarriage. Hum Reprod Update 2003; 9:163-174.
43. Bates MD, Quenby S, Takakuwa K, et al. Aberrant cytokine production by peripheral blood mononuclear cells in recurrent pregnancy loss? Hum Reprod 2002; 17:2439-2444.
44. Scarpellini F, Sbracia M. Use of granulocyte colony-stimulating factor for the treatment of unexplained recurrent miscarriage: a randomised controlled trial. Hum Reprod 2009; 24:2703-2708.
45. Brigham SA, Conlon C, Farquharson RG. A longitudinal study of pregnancy outcome following idiopathic recurrent miscarriage. Hum Reprod 1999; 14:2868-2871.
46. Kaandorp S, Di Nisio M, Goddijn M, Middeldorp S. Aspirin or anticoagulants for treating recurrent miscarriage in women without antiphospholipid syndrome. Cochrane Database Syst Rev 2009:CD004734.
47. Mantha S, Bauer KA, Zwicker JI. Low molecularweight heparin to achieve live birth following unexplained pregnancy loss: a systematic review. J Thromb Haemost 2010; 8:263-268.
48. Clark P, Walker ID, Langhorne P, et al. SPIN (Scottish Pregnancy Intervention) study: a multicenter, randomized controlled trial of low-molecular-weight heparin and low-dose aspirin in women with recurrent miscarriage. Blood 2010; 115:4162-4167.
49. Haas DM, Ramsey PS. Progestogen for preventing miscarriage. Cochrane Database Syst Rev 2008:CD003511.
50. Porter TF, LaCoursiere Y, Scott JR. Immunotherapy for recurrent miscarriage. Cochrane Database Syst Rev 2006:CD000112.